Cargando…

The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma

Oncolytic adenoviruses are modified based on adenovirus serotype 5 (Ad5), which belongs to subgroup C and depends on Coxsackie-adenovirus receptor (CAR) to recognize target cells. However, expression of CAR is generally low or lost in certain tumors including hepatocellular carcinoma (HCC). By contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, JIANG, LIU, HUI, LI, LINFANG, WU, HONGPING, WANG, CHUNHONG, YAN, ZI, WANG, YING, SU, CHANGQING, JIN, HUAJUN, ZHOU, FUPING, WU, MENGCHAO, QIAN, QIJUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597539/ https://www.ncbi.nlm.nih.gov/pubmed/23292657 http://dx.doi.org/10.3892/or.2012.2217

Ejemplares similares

Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
por: Ang, Lin, et al.
Publicado: (2022)

Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells
por: Jin, Huajun, et al.
Publicado: (2011)

Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are Independent Risk Predictors of Short-Term Mortality in Patients with Acute Coronary Syndromes
por: de Jager, Saskia C. A., et al.
Publicado: (2012)

Hyperactivated Signaling Pathways of Chemokine RANTES/CCL5 in Osteopathies of Jawbone in Breast Cancer Patients—Case Report and Research
por: Lechner, Johann, et al.
Publicado: (2014)

The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors
por: Wang, Ying, et al.
Publicado: (2015)

Chemokine RANTES/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments in the horizon?
por: Lechner, Johann, et al.
Publicado: (2015)

CCL5/RANTES Gene Polymorphisms in Slavonic Patients with Myocardial Infarction
por: Tereshchenko, Irina P., et al.
Publicado: (2011)

The Involvement of the Chemokine RANTES in Regulating Luminal Acidification in Rat Epididymis
por: Feng, Xiao, et al.
Publicado: (2020)

Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells
por: Øynebråten, Inger, et al.
Publicado: (2015)

Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation
por: Lechner, Johann, et al.
Publicado: (2015)

RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2023)

The CC chemokine RANTES as a potential contributor to breast cancer progression
por: Azenshtein, E, et al.
Publicado: (2001)

Undetected Jawbone Marrow Defects as Inflammatory and Degenerative Signaling Pathways: Chemokine RANTES/CCL5 as a Possible Link Between the Jawbone and Systemic Interactions?
por: Lechner, Johann, et al.
Publicado: (2021)

Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells
por: Peng, Xinrong, et al.
Publicado: (2012)

Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension
por: Mikolajczyk, Tomasz P., et al.
Publicado: (2016)

Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model
por: Iaia, Ilenia, et al.
Publicado: (2022)

Aseptic-avascular osteonecrosis: local “silent inflammation” in the jawbone and RANTES/CCL5 overexpression
por: Lechner, Johann, et al.
Publicado: (2017)

Increased CCL-5 (RANTES) Gene Expression in the Choroid Plexus of Dogs with Canine Leishmaniosis
por: Silva, José Eduardo dos Santos, et al.
Publicado: (2023)

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy
por: Wang, Weiguo, et al.
Publicado: (2013)

Na(+)/H(+)-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells
por: Gong, Yao-Yu, et al.
Publicado: (2022)

Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21
por: Unver, Nese
Publicado: (2021)

HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3
por: Hadida, Fabienne, et al.
Publicado: (1998)

HHV-6 Infection and Chemokine RANTES Signaling Pathway Disturbance in Patients with Autoimmune Thyroiditis
por: Sultanova, Alina, et al.
Publicado: (2020)

Pyocyanin induces NK92 cell apoptosis via mitochondrial damage and elevated intracellular Ca(2+)
por: Li, Ting, et al.
Publicado: (2018)

RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway
por: Maillard, Loïc, et al.
Publicado: (2014)

CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5
por: Chou, Szu-Yi, et al.
Publicado: (2016)

RANTES/CCL5 Signaling from Jawbone Cavitations to Epistemology of Multiple Sclerosis – Research and Case Studies
por: Lechner, Johann, et al.
Publicado: (2021)

The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2023)

Reduction of Inflammatory RANTES/CCL5 Serum Levels by Surgery in Patients with Bone Marrow Defects of the Jawbone
por: Diederich, Joé, et al.
Publicado: (2023)

NK cells and chemokines
por: Gismondi, Angela, et al.
Publicado: (2010)

Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine
por: Lechner, Johann, et al.
Publicado: (2019)

CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients
por: Farangis, Fatehi, et al.
Publicado: (2017)

Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
por: Chen, Ping, et al.
Publicado: (2014)

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice
por: Mrowietz, U, et al.
Publicado: (1999)

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis
por: Rodríguez-Frade, José M., et al.
Publicado: (1999)

Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects
por: Wang, Xiao, et al.
Publicado: (2022)

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
por: Li, Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r6o8ancm47l4nkb8i7t6r8s2qr